Cindy Weinstein

Statistics

Publications

Citations

169

H-Index

Active since

2011

Affiliations

Merck & Co., Inc., Rahway, NJ, USA (United States)(Current)

The Medical Oncology Centre of Rosebank

Reliant Medical Group

Desert Regional Medical Center

Martin Luther University Halle-Wittenberg

Cindy Weinstein is an author at Merck & Co., Inc., Rahway, NJ, USA (United States) specializing in pharmacotherapy, asthma management, and pulmonology.

ORCID

Publications per year

2011–2023

Publications

Single-dose fosaprepitant for the prevention of chemotherapy-induced nausea and vomiting associated with moderately emetogenic chemotherapy: results of a randomized, double-blind phase III trial

Cindy Weinstein, Karin Jordan, S.A. Green et al. · Annals of Oncology · 2015 · 82 citations · Full text

Medicine, Pharmacology, Pharmacotherapy +17

Serious asthma events with mometasone furoate plus formoterol compared with mometasone furoate

Cindy Weinstein, Nicholas Ryan, Tulin Shekar et al. · Journal of Allergy and Clinical Immunology · 2018 · 21 citations

Pharmacy, Internal Medicine, Pharmacotherapy +12

Patient Satisfaction with a Pressurized Metered-Dose Inhaler with an Integrated Dose Counter Containing a Fixed-Dose Mometasone Furoate/Formoterol Combination

Craig LaForce, Cindy Weinstein, Robert A. Nathan et al. · Journal of Asthma · 2011 · 17 citations

Pharmacy, Clinical Pharmacy, Pharmacotherapy +17

Dose counter performance of mometasone furoate/formoterol inhalers in subjects with asthma or COPD

Cindy Weinstein, Heribert Staudinger, Ian Scott et al. · Respiratory Medicine · 2011 · 17 citations · Full text

Pharmacy, Pharmacology, Pharmacotherapy +14

Evaluation of factors contributing to the response to fosaprepitant in a heterogeneous, moderately emetogenic chemotherapy population: an exploratory analysis of a randomized phase III trial

Cindy Weinstein, Karin Jordan, Stuart A. Green et al. · Supportive Care in Cancer · 2018 · 12 citations

Medicine, Oncology, Pharmacology +12

1–5 of 7